KASINGER JAMES R.
Reporting owner on Forms 3, 4 and 5, CIK 1708172.
KASINGER JAMES R. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CRSP · CRISPR Therapeutics AGCIK 1674416 | officer (General Counsel and Secretary) | 1 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CRSP · CRISPR Therapeutics AGCommon Shares | 2026-10-06 | M exercised | +1,990 | $13.62 | 96,774 | Form 4 |
| CRSP · CRISPR Therapeutics AGCommon Shares | 2026-10-06 | S sold | -1,990 | $60.0408 | 94,784 | Form 4 |
| CRSP · CRISPR Therapeutics AGStock Option (Right to Buy), derivative | 2026-10-06 | M exercised | -1,990 | $0 | 81,242 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-418101 | CRISPR Therapeutics AG | 2026-10-08 |